BETAJECT
BETAJECT
Discontinued
DIN Number
02237835
Drug Class
Human
Market Date
Jul 2, 1998
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02237835
AIG Number0206301001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H02AB01 BETAMETHASONE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntralesional
,
Intra-Articular
,
Intramuscular
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)Active
Strength: 3 MG / ML
Monograph: BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)
BETAMETHASONE ACETATEActive
Strength: 3 MG / ML
Monograph: BETAMETHASONE ACETATE